Paltusotine
CAS 2172870-89-0Small Molecule
Overview
Paltusotine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL5267842).
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Paltusotine expires 25 Mar 2044 and exclusivity 25 Sept 2032. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 3-[4-(4-aminopiperidin-1-yl)-3-(3,5-difluorophenyl)quinolin-6-yl]-2-hydroxybenzonitrile
- Canonical SMILES
- C1CN(CCC1N)C2=C3C=C(C=CC3=NC=C2C4=CC(=CC(=C4)F)F)C5=CC=CC(=C5O)C#N
- InChIKey
- GHILNKWBALQPDP-UHFFFAOYSA-N
Verified Supplier Partner
Do you supply Paltusotine? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.